• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人组织型纤溶酶原激活剂基因

The human tissue plasminogen activator gene.

作者信息

Degen S J, Rajput B, Reich E

出版信息

J Biol Chem. 1986 May 25;261(15):6972-85.

PMID:3009482
Abstract

The nucleotide sequence of the human tissue plasminogen activator (t-PA) gene has been established. A total of 36,594 base pairs (bp) was sequenced; this included 32,720 bp from the site of initiation of transcription to the polyadenylation site, in addition to 3,530 and 344 bp of 5' and 3' flanking DNA, respectively. Thirteen intervening sequences divide the gene into 14 coding regions; the size range for exons is 43-914 bp, while that for introns is 111-14,257 bp. The gene and 5' flanking region contain 28 copies of Alu repetitive DNA and a single KpnI repeat. The transcription initiation site was identified by S1 nuclease, exonuclease VII, and primer extension analysis as an A residue; "TATA" and "CAAT" boxes are located in the expected positions upstream of this proposed site. Results of the analysis of the gene sequence and its comparison with data banks are described. The protein and gene structures of tissue and urokinase plasminogen activator are compared; based on these features the evolutionary relationship of the two human plasminogen activators appears to be close.

摘要

人类组织型纤溶酶原激活剂(t-PA)基因的核苷酸序列已被确定。共测序了36594个碱基对(bp);其中包括从转录起始位点到聚腺苷酸化位点的32720 bp,此外还有5'和3'侧翼DNA分别为3530 bp和344 bp。13个间隔序列将该基因分为14个编码区;外显子的大小范围为43 - 914 bp,而内含子的大小范围为111 - 14257 bp。该基因和5'侧翼区域包含28个Alu重复DNA拷贝和一个KpnI重复序列。通过S1核酸酶、核酸外切酶VII和引物延伸分析确定转录起始位点为一个A残基;“TATA”盒和“CAAT”盒位于该推测位点上游的预期位置。描述了基因序列分析结果及其与数据库数据的比较。比较了组织型和尿激酶型纤溶酶原激活剂的蛋白质和基因结构;基于这些特征,两种人类纤溶酶原激活剂的进化关系似乎很近。

相似文献

1
The human tissue plasminogen activator gene.人组织型纤溶酶原激活剂基因
J Biol Chem. 1986 May 25;261(15):6972-85.
2
The murine urokinase-type plasminogen activator gene.
Biochemistry. 1987 Dec 15;26(25):8270-9. doi: 10.1021/bi00399a038.
3
Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences.人纤溶酶原激活物抑制剂-1基因。启动子和结构基因核苷酸序列。
J Biol Chem. 1988 Jul 5;263(19):9129-41.
4
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.人组织型纤溶酶原激活剂结构基因(包括其5'侧翼区)的分离与特性分析。
J Biol Chem. 1985 Sep 15;260(20):11223-30.
5
The structure of the TATA-less rat tissue-type plasminogen activator gene. Species-specific sequence divergences in the promoter predict differences in regulation of gene expression.无TATA盒的大鼠组织型纤溶酶原激活剂基因的结构。启动子中的物种特异性序列差异预示着基因表达调控的差异。
J Biol Chem. 1990 Feb 5;265(4):2022-7.
6
Complete sequence and structure of the gene for human adenosine deaminase.人类腺苷脱氨酶基因的完整序列和结构
Biochemistry. 1986 Dec 16;25(25):8234-44. doi: 10.1021/bi00373a017.
7
Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region.人类凝血因子XII基因的特征。内含子/外显子基因结构及5'侧翼区域分析。
J Biol Chem. 1987 Oct 5;262(28):13662-73.
8
Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene.大鼠肝细胞溶质磷酸烯醇丙酮酸羧激酶(GTP)。蛋白质、信使核糖核酸及基因的结构。
J Biol Chem. 1985 Sep 5;260(19):10748-60.
9
The organization of the human-plasminogen-activator-inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family.人纤溶酶原激活物抑制剂-1基因的组织。对丝氨酸蛋白酶抑制剂家族进化的影响。
Eur J Biochem. 1988 Oct 1;176(3):609-16. doi: 10.1111/j.1432-1033.1988.tb14320.x.
10
Isolation and characterization of the rat plasminogen activator inhibitor-1 gene.大鼠纤溶酶原激活物抑制剂-1基因的分离与鉴定
J Biol Chem. 1990 Feb 5;265(4):2078-85.

引用本文的文献

1
Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms.纤维蛋白溶解丝氨酸蛋白酶、治疗性丝氨酸蛋白酶抑制剂与炎症:火焰舞者与风暴。
Front Cardiovasc Med. 2021 Mar 25;8:648947. doi: 10.3389/fcvm.2021.648947. eCollection 2021.
2
Structural Biology and Protein Engineering of Thrombolytics.溶栓剂的结构生物学与蛋白质工程
Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019.
3
Ovulation: Parallels With Inflammatory Processes.排卵:与炎症过程的相似性。
Endocr Rev. 2019 Apr 1;40(2):369-416. doi: 10.1210/er.2018-00075.
4
Biological functions of fucose in mammals.哺乳动物中岩藻糖的生物学功能。
Glycobiology. 2017 Jul 1;27(7):601-618. doi: 10.1093/glycob/cwx034.
5
Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.调控元件DNA甲基化对组织型纤溶酶原激活剂基因表达的影响。
PLoS One. 2016 Dec 14;11(12):e0167588. doi: 10.1371/journal.pone.0167588. eCollection 2016.
6
The anticoagulant effect of PGI2S and tPA in transgenic umbilical vein endothelial cells is linked to up-regulation of PKA and PKC.前列环素类似物(PGI2S)和组织型纤溶酶原激活剂(tPA)在转基因脐静脉内皮细胞中的抗凝作用与蛋白激酶A(PKA)和蛋白激酶C(PKC)的上调有关。
Int J Mol Sci. 2014 Feb 19;15(2):2826-39. doi: 10.3390/ijms15022826.
7
Haplotype Based Association Study between t-PA Gene and Essential Hypertension.基于单倍型的组织型纤溶酶原激活剂基因与原发性高血压的关联研究
Int J Biomed Sci. 2006 Jun;2(2):166-71.
8
Cerebral small vessel disease: genetic risk assessment for prevention and treatment.脑小血管病:预防和治疗的遗传风险评估
Mol Diagn Ther. 2008;12(3):145-56. doi: 10.1007/BF03256279.
9
4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.土耳其多囊卵巢综合征患者中PAI - 1基因的4G/5G多态性及TPA基因的Alu重复序列I/D多态性
J Assist Reprod Genet. 2007 Sep;24(9):412-8. doi: 10.1007/s10815-007-9160-7. Epub 2007 Jul 28.
10
Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?软骨破坏的蛋白水解机制:关节炎治疗的靶点?
Clin Mol Pathol. 1995 Aug;48(4):M167-77. doi: 10.1136/mp.48.4.m167.